Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy

NCT03708523 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-10-17

No results posted yet for this study

Summary

This study tried to highlight the predictive value of the morning postoperative cortisol levels, which can act as the prognosis value of the postoperative pituitary function, providing future medication advices for improving patients' safety of drugs.

Conditions

  • Hypopituitarism

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Fon-Yih Tsuang, MD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03708523 on ClinicalTrials.gov